Global News Today | 2 Min News | The Daily News Now!
A medical titan lost too soon: Dr. Richard Scolyer, 59, battled an aggressive brain tumor with courage and innovation, pioneering a world-first experimental treatment rooted in his own groundbreaking melanoma research. Alongside Professor Georgina Long, he transformed advanced melanoma from a death sentence into a condition where half of patients are now cured. Facing his own glioblastoma, he refused to accept defeat, opting for a personalized immunotherapy approach that sparked a new U.S. clinical trial. His legacy lives on through his mentorship, his relentless curiosity, and his call to fund and champion life-saving science — leaving behind a world richer for his brilliance.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/685543b3e7e6ee39